advertisement
Oncology and Hematology
1776
Episodes 65-80 of 392
- Clinician's Roundtable
Etranacogene Dezaparvovec for Hemophilia B: Efficacy and Safety Four Years Post-Infusion
Etranacogene Dezaparvovec for Hemophilia B: Efficacy and Safety Four Years Post-Infusion